A-Z
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
- 0-9
Classification
Publication

- Full text
- Title
- Author
- ISBN/ISSN
- Publisher
AdvancedSearch
- AdvancedSearch
- Search help

Peptide Receptor Radionuclide Therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATOC in Advanced Neuroendocrine Tumors: Results from a Danish Cohort Treated in Switzerland

Publisher： Karger

E-ISSN： 1423-0194|93|3|189-196

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.93, Iss.3, 2011-02, pp. : 189-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy

By

Neuroendocrinology, Vol. 97, Iss. 1, 2012-01 ,pp. : 74-85

Access to resources Recommend Favorite

Impact of Multiphase ⁶⁸Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors

By

Neuroendocrinology, Vol. 91, Iss. 1, 2009-12 ,pp. : 101-109

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

By

Neuroendocrinology, Vol. 90, Iss. 2, 2009-08 ,pp. : 220-226

Access to resources Recommend Favorite

Treatment with the Radiolabelled Somatostatin Analog ¹⁷⁷Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

By

Neuroendocrinology, Vol. 97, Iss. 4, 2013-05 ,pp. : 347-354

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

By

Neuroendocrinology, Vol. 105, Iss. 3, 2017-04 ,pp. : 295-309

Access to resources Recommend Favorite